<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/shared/xsl/wikiorss_xsl.jsp"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:review="http://api.wikio.com/syndication/feed/module/review/1.0" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Wikio - Drug Trials</title>
    <link>http://www.wikio.co.uk/health-fitness/drug_trials</link>
    <description>Wikio - Health-Fitness - Drug Trials</description>
    <item>
      <title>India investigates drug trial baby deaths (The Telegraph)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68355776</link>
      <description>&lt;p&gt;&lt;A HREF="http://www.wikio.co.uk/tag/India" class="deep u"&gt;India&lt;/A&gt; is to investigate the deaths of 49 babies who died during clinical &lt;b&gt;drug&lt;/b&gt;s &lt;b&gt;trial&lt;/b&gt;s conducted in the capital New Delhi over the past two and a half years.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.telegraph.co.uk"  target="_blank"&gt;The Telegraph&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.telegraph.co.uk/newsfeed/rss/news-international_news.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/high-tech/computer_industry" target="_blank"&gt;Computer industry&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/international/asia/india" target="_blank"&gt;India&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/international" target="_blank"&gt;International&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/high-tech/computer_industry/semi-conductors" target="_blank"&gt;Semi-Conductors&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 20 Aug 2008 12:55:25 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68355776</guid>
      <dc:date>2008-08-20T12:55:25Z</dc:date>
    </item>
    <item>
      <title>Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate For Rheumatoid Arthritis (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68467234</link>
      <description>&lt;p&gt;Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced that it has acquired an oral, once-daily candidate for the treatment of rheumatoid arthritis (RA) which has completed a 160 patient, multi-center, double-blind, randomized, placebo-controlled...&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Thu, 21 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68467234</guid>
      <dc:date>2008-08-21T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Nomir Medical To Present Positive Onychomycosis Data For Its Noveon(R) Dual Wavelength Device (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68103283</link>
      <description>&lt;p&gt;Nomir Medical Technologies, a leader in the development of optical energy technologies for anti-infective medical applications, announced that the Company will present an abstract detailing positive in vitro and in vivo human data from its study of onychomycosis (toe nail fungus) using Noveon®, a novel dual wavelength optical energy device.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Mon, 18 Aug 2008 10:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68103283</guid>
      <dc:date>2008-08-18T10:00:00Z</dc:date>
    </item>
    <item>
      <title>Safer Alternative To Heparin Created By Researchers (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68103284</link>
      <description>&lt;p&gt;&lt;A HREF="http://www.wikio.co.uk/tag/Robert+Linhardt" class="deep u"&gt;Robert Linhardt&lt;/A&gt; has spent years stitching together minuscule carbohydrates to build a more pure and safer alternative to the commonly used and controversial blood thinner heparin. At the national conference of the American Chemical Society on August 17, 2008, Linhardt announced that his research team may have accomplished this task by building the first fully synthetic heparin. Their creation is the...&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Mon, 18 Aug 2008 10:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=68103284</guid>
      <dc:date>2008-08-18T10:00:00Z</dc:date>
    </item>
    <item>
      <title>Study Shows Epidural Anaesthesia Is Safe But Only Slightly Improves Survival (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67331846</link>
      <description>&lt;p&gt;A study of quarter of a million patients has shows that epidural anaesthesia / analgesia* (EA) is safe for patients undergoing intermediate to high-risk surgery other than cardiac surgery. However people given EA have only a very slightly increased survival compared with those who do not. These are the conclusions of authors of an Article published early Online and in an upcoming edition of The Lancet....&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/entertainment/video_games/video_games_industry/electronic_arts" target="_blank"&gt;Electronic Arts&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Mon, 11 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67331846</guid>
      <dc:date>2008-08-11T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Geron Initiates Clinical Trial Of GRN163L In Combination With Paclitaxel And Bevacizumab In Patients With Breast Cancer (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67331848</link>
      <description>&lt;p&gt;&lt;A HREF="http://www.wikio.co.uk/tag/Geron" class="deep u"&gt;Geron&lt;/A&gt; Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer. The primary objective of the Phase I/II, dose escalation study is to determine the safety, maximum tolerated dose (MTD) and objective response rate of GRN163L when administered intravenously in combination with...&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money" target="_blank"&gt;Money&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange/nasdaq" target="_blank"&gt;NASDAQ&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange" target="_blank"&gt;Stock exchange&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Mon, 11 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67331848</guid>
      <dc:date>2008-08-11T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Singapore Court Postpones Australian TV Journalist's Drug Trial (Singapore News Alternative)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67320908</link>
      <description>&lt;p&gt;Bernama.com 11 Aug 2008 SINGAPORE, Aug 11 (Bernama) -- The &lt;b&gt;drug&lt;/b&gt; &lt;b&gt;trial&lt;/b&gt; involving an Australian television reporter from the Australian Broadcasting Corporation (ABC), which was fixed for today, has been shifted to Aug 19. This is the third time in three weeks that the hearing has been postponed. Hamidul Haq, counsel for the 41-year-old journalist, Lloyd Peter Gerard, Hamidul Haq when contacted...&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://singaporenewsalternative.blogspot.com/"  target="_blank"&gt;Singapore News Alternative&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://singaporenewsalternative.blogspot.com/feeds/posts/default" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/international/asia/singapore" target="_blank"&gt;Singapore&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Mon, 11 Aug 2008 05:14:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67320908</guid>
      <dc:date>2008-08-11T05:14:00Z</dc:date>
    </item>
    <item>
      <title>Your Black Hip Hop: Baby "Birdman" Faces Drug Trial (Music News)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67270017</link>
      <description>&lt;p&gt;Hip-hop mogul BRYAN ‘BABY’ WILLIAMS will stand &lt;b&gt;trial&lt;/b&gt; in October (0 on &lt;b&gt;drug&lt;/b&gt; possession charges. The rapper - also known as Birdman - appeared in court for a preliminary hearing in &lt;A HREF="http://www.wikio.co.uk/tag/Kingsport" class="deep u"&gt;Kingsport&lt;/A&gt;, &lt;A HREF="http://www.wikio.co.uk/tag/Tennessee" class="deep u"&gt;Tennessee&lt;/A&gt; on Tuesday (29Jul08), … Original post by yourblackworld&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://southernoracle.net"  target="_blank"&gt;Music News&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://southernoracle.net/?feed=rss2" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Sun, 10 Aug 2008 08:25:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67270017</guid>
      <dc:date>2008-08-10T08:25:00Z</dc:date>
    </item>
    <item>
      <title>DOR BioPharma Announces Initiation Of Second Human Clinical Trial For RiVaxTM, Its Ricin Toxin Vaccine (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67038695</link>
      <description>&lt;p&gt;&lt;A HREF="http://www.wikio.co.uk/tag/DOR+BioPharma" class="deep u"&gt;DOR BioPharma&lt;/A&gt;, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company, announced that one of its academic development partners has initiated a second human clinical trial of RiVax™ in healthy volunteers. RiVax™ is a recombinant subunit vaccine designed to induce protection against exposure to ricin toxin, a category B biothreat.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Thu, 07 Aug 2008 23:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=67038695</guid>
      <dc:date>2008-08-07T23:00:00Z</dc:date>
    </item>
    <item>
      <title>Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial Of Its Oral Insulin Capsule (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66936957</link>
      <description>&lt;p&gt;Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of oral delivery systems, announced successful results from the clinical trial of its oral insulin capsule, ORMD 0801. The trial demonstrated that the product had a good safety profile and well tolerated and effective in lowering blood glucose levels in patients with type 2 diabetes.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Thu, 07 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66936957</guid>
      <dc:date>2008-08-07T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Abbott's Kaletra(R) Tablet Dosed Once-Daily Or Twice-Daily Demonstrated Similar Clinical Results Across Race And Gender Lines (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66814984</link>
      <description>&lt;p&gt;Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (&lt;A HREF="http://www.wikio.co.uk/tag/NYSE" class="deep u"&gt;NYSE&lt;/A&gt;: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar results for controlling the virus (reducing the amount of HIV-1) and improving the immune system&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money" target="_blank"&gt;Money&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange/new_york_stock_exchange" target="_blank"&gt;New York Stock Exchange&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange" target="_blank"&gt;Stock exchange&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/international/international_organisations/united_nations/world_health_organization" target="_blank"&gt;World Health Organization&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 08:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66814984</guid>
      <dc:date>2008-08-06T08:00:00Z</dc:date>
    </item>
    <item>
      <title>Ninety-Six Week Data On Tibotec Investigational NNRTI, TMC278, Presented At AIDS 2008 (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66814988</link>
      <description>&lt;p&gt;New phase IIb data from Tibotec Pharmaceuticals Ltd. provides additional information on the safety and efficacy of TMC278, the company's once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), as part of HIV combination therapy in treatment-naive adults. These findings were presented today at the International AIDS Conference (AIDS 2008) in Mexico City.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 08:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66814988</guid>
      <dc:date>2008-08-06T08:00:00Z</dc:date>
    </item>
    <item>
      <title>FDA Accepts Streamlined Phase 3 Development Plan For Q8003IR 'Dual Opioid' Pain Therapy (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66814997</link>
      <description>&lt;p&gt;QRxPharma Limited (ASX: QRX; OTCQX: QRXPY), a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapies for pain and central nervous system (CNS) disorders, announced today that the U.S.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 08:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66814997</guid>
      <dc:date>2008-08-06T08:00:00Z</dc:date>
    </item>
    <item>
      <title>Cara Therapeutics Announces Successful Completion Of Phase I Clinical Trial Of Novel Analgesic, CR845 (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66815001</link>
      <description>&lt;p&gt;&lt;A HREF="http://www.wikio.co.uk/tag/Cara+Therapeutics" class="deep u"&gt;Cara Therapeutics&lt;/A&gt;, Inc. announced completion of a Phase I clinical trial for its second-generation, peripherally acting kappa opioid agonist, CR845, under development for the treatment of acute and chronic pain. The drug candidate was safe and well-tolerated after intravenous infusion, and resulted in plasma levels of CR845 expected to be associated with clinical analgesic activity.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 08:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66815001</guid>
      <dc:date>2008-08-06T08:00:00Z</dc:date>
    </item>
    <item>
      <title>Medarex Announces Allowance Of Investigational New Drug Application For Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105 (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66815003</link>
      <description>&lt;p&gt;&lt;A HREF="http://www.wikio.co.uk/tag/Medarex" class="deep u"&gt;Medarex&lt;/A&gt;, Inc. (Nasdaq: MEDX) announced the allowance of an investigational new drug application (IND) filed with the U.S. Food &amp; Drug Administration (FDA) for MDX-1105, for the treatment of patients with selected advanced or recurrent solid tumors, specifically renal cell carcinoma, melanoma, non-small cell lung cancer or epithelial ovarian cancer.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/economy/biotechnologies" target="_blank"&gt;Biotechnologies&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/economy/biotechnologies/medarex" target="_blank"&gt;Medarex&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money" target="_blank"&gt;Money&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange" target="_blank"&gt;Stock exchange&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 08:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66815003</guid>
      <dc:date>2008-08-06T08:00:00Z</dc:date>
    </item>
    <item>
      <title>Pharmasset Reports Preliminary Results Of A 4-week Combination Study Of R7128 For The Treatment Of Chronic Hepatitis C (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66815005</link>
      <description>&lt;p&gt;Pharmasset, Inc. (Nasdaq: VRUS) announces the preliminary results of the third cohort of a 4-week Phase 1 clinical trial evaluating R7128 1000mg twice daily (BID) in combination with the standard of care (SOC), Pegasys(R) (pegylated interferon) plus Copegus(R) (ribavirin), in 31 treatment-naive patients chronically infected with hepatitis C virus (HCV) genotype 1.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money" target="_blank"&gt;Money&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange/nasdaq" target="_blank"&gt;NASDAQ&lt;/a&gt;, &lt;a href="http://www.wikio.co.uk/money/stock_exchange" target="_blank"&gt;Stock exchange&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 08:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66815005</guid>
      <dc:date>2008-08-06T08:00:00Z</dc:date>
    </item>
    <item>
      <title>Argos Therapeutics' Arcelis Personalized Immunotherapy Platform In HIV Achieves Primary Endpoint In Phase 1 Trial (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66808138</link>
      <description>&lt;p&gt;Argos Therapeutics announced the presentation of positive immune response data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy (ART). AGS-004 achieved the trial's primary endpoint of induction of T cell response to patient-specific HIV antigens. AGS-004 is a personalized HIV immunotherapy generated by the Company's Arcelis™ technology.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66808138</guid>
      <dc:date>2008-08-06T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Clinxus Partnership Devises Improved Tests To Detect Kidney Damage For New Drugs In Development (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66808140</link>
      <description>&lt;p&gt;The Critical Path Institute (C-Path) Predictive Safety Testing Consortium (PSTC), which includes &lt;A HREF="http://www.wikio.co.uk/tag/Grand+Rapids" class="deep u"&gt;Grand Rapids&lt;/A&gt;-based ClinXus, has identified seven new tests to assess the safety of new drugs in development, specifically to monitor the drugs' effects on the kidneys. The U.S.&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66808140</guid>
      <dc:date>2008-08-06T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Bionor Immuno Advances HIV Peptide-Based Therapeutic Immunization Program With Start Of A Phase IIb Trial In U.S. And Europe (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66808142</link>
      <description>&lt;p&gt;Bionor Immuno announced that it has advanced its efforts to develop the first HIV therapeutic immunization with the dosing of patients in a global Phase 2b clinical trial of the company's lead candidate (Vacc-4x). This randomized, double-blind, placebo-controlled trial is being conducted in HIV infected patients with the potential to offer an important drug free break in their current antiretroviral...&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Wed, 06 Aug 2008 07:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66808142</guid>
      <dc:date>2008-08-06T07:00:00Z</dc:date>
    </item>
    <item>
      <title>Eating Fish May Prevent Memory Loss And Stroke In Old Age (Medical News Today)</title>
      <link>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66693416</link>
      <description>&lt;p&gt;Eating tuna and other types of fish may help lower the risk of cognitive decline and stroke in healthy older adults, according to a study published in the August 5, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, 3,660 people age 65 and older underwent brain scans to detect silent brain infarcts, or small lesions in the brain that can cause loss of...&lt;/p&gt;&lt;p&gt;Source : &lt;a href="http://www.medicalnewstoday.com"  target="_blank"&gt;Medical News Today&lt;/a&gt; (&lt;a href="http://www.wikio.co.uk/subscribe?url=http://www.medicalnewstoday.com/rss/clinicaltrials.xml" target="_blank"&gt;subscribe&lt;/a&gt;)&lt;/p&gt;&lt;p&gt;Explore :  &lt;a href="http://www.wikio.co.uk/health-fitness" target="_blank"&gt;Health-Fitness&lt;/a&gt;&lt;/p&gt;</description>
      <pubDate>Tue, 05 Aug 2008 09:00:00 GMT</pubDate>
      <guid>http://www.wikio.co.uk/health-fitness/drug_trials?rinfoid=66693416</guid>
      <dc:date>2008-08-05T09:00:00Z</dc:date>
    </item>
  </channel>
</rss>

